Article Text

Download PDFPDF

Causal analysis of H1N1pdm09 influenza infection risk in a household cohort
  1. Yohann Mansiaux1,2,
  2. Nicolas Salez3,
  3. Nathanael Lapidus1,2,4,
  4. Michel Setbon5,
  5. Laurent Andreoletti6,7,
  6. Marianne Leruez-Ville8,
  7. Simon Cauchemez9,
  8. Marie-Lise Gougeon10,
  9. Frédéric Vély11,12,13,14,
  10. Michael Schwarzinger15,16,17,
  11. Laurent Abel18,19,
  12. Rosemary Markovic Delabre1,2,
  13. Antoine Flahault20,21,
  14. Xavier de Lamballerie3,
  15. Fabrice Carrat1,2,4
  1. 1INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France
  2. 2UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Universités, Paris, France
  3. 3IRD French Institute of Research for Development, EHESP French School of Public Health, UMR_D 190 "Emergence des Pathologies Virales", Aix Marseille Univ, Marseille, France
  4. 4Public Health Unit, Saint-Antoine Hospital, Paris, France
  5. 5IRD French Institute of Research for Development, EHESP French School of Public Health, EPV UMR_D 190 "Emergence des Pathologies Virales", CNRS-Aix Marseille Université, Marseille, France
  6. 6Laboratoire de Virologie médicale et moléculaire Hôpital Robert Debré, CHU Reims, Reims, France
  7. 7Faculté de Médecine, EA 4684, Reims, France
  8. 8Laboratory of Virology, Hospital Necker-.Enfants-malades, Assistance Publique-Hôpitaux de Paris APHP—University Paris Descartes, Sorbonne Paris Cité, Paris, France
  9. 9Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, Paris, France
  10. 10Antiviral Immunity, Biotherapy and Vaccine Unit, Institut Pasteur, Paris, France
  11. 11Centre d'Immunologie de Marseille-Luminy, INSERM, U1104, Marseille, France
  12. 12CNRS, UMR7280, Marseille, France
  13. 13Aix Marseille Université, UM2, Marseille, France
  14. 14Service d'Immunologie, Assistance Publique—Hôpitaux de Marseille, Hôpital de la Conception, Marseille, France
  15. 15IAME, UMR 1137, INSERM, Paris, France
  16. 16IAME, UMR 1137, Sorbonne Paris Cité, Univ Paris Diderot, Paris, France
  17. 17Translational Health Economics Network, Paris, France
  18. 18Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France
  19. 19Imagine Institute, Paris Descartes University, Sorbonne Paris Cité, Paris, France
  20. 20Centre Virchow-Villermé, Descartes, Université Sorbonne Paris Cité, Paris, France
  21. 21Global Health Institute, University of Geneva, Geneva, Switzerland
  1. Correspondence to Yohann Mansiaux, Equipe 2, UMRS-1136, Faculté de Médecine Saint Antoine, 27 Rue Chaligny, 75571 Paris, Cedex 12, France; yohann.mansiaux{at}upmc.fr

Abstract

Background Obtaining a comprehensive quantitative figure of the determinants of influenza infection will help identify priority targets for future influenza mitigation interventions. We developed an original causal model integrating highly diverse factors and their dependencies, to identify the most critical determinants of pandemic influenza infection (H1N1pdm09) during the 2010–2011 influenza season.

Methods We used data from 601 households (1450 participants) included in a dedicated cohort. Structural equations were used to model direct and indirect relationships between infection and risk perception, compliance with preventive behaviours, social contacts, indoor and outdoor environment, sociodemographic factors and pre-epidemic host susceptibility. Standardised estimates (βstd) were used to assess the strength of associations (ranging from −1 for a completely negative association to 1 for a completely positive association).

Results Host susceptibility to H1N1pdm09 and compliance with preventive behaviours were the only two factors directly associated with the infection risk (βstd=0.31 and βstd=−0.21). Compliance with preventive behaviours was influenced by risk perception and preventive measures perception (βstd=0.14 and βstd=0.27). The number and duration of social contacts were not associated with H1N1pdm09 infection.

Conclusions Our findings suggest that influenza vaccination in addition to public health communication campaigns focusing on personal preventive measures should be prioritised as potentially efficient interventions to mitigate influenza epidemics.

  • BIOSTATISTICS
  • EPIDEMIOLOGY
  • INFLUENZA

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement: